Forbes September 16, 2021
Russell Flannery

Prenetics Group, a Hong Kong-based genomic and diagnostic testing firm, and Artisan Acquisition, a Nasdaq-listed SPAC founded by businessman Adrian Cheng, on Wednesday announced a merger agreement that would value Prenetics at $1.2 billion.

The transaction would make Prenetics the first unicorn from Hong Kong to be publicly listed in any market, according to a Prenetics press release.  

Prenetics, whose investors include Alibaba Group, will receive up to $459 million in cash, including up to $339 million of cash currently held in Artisan’s trust account, and $120 million through purchase agreements from Aspex, PAG, Lippo, Dragonstone, Xen Capital and others, along with...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
Better Medicare Alliance: MA adds $32.5B in value to Medicare
Oak Street Health Acquires Telehealth Company RubiconMD for $130 Million
Ascension, AdventHealth unwind joint venture Amita Health in Chicago
6 recent pharmaceutical deals, acquisitions
How PE Is Pushing Behavioral Health M&A to New Dealmaking Heights